국가임상시험지원재단

페이스북 유튜브

Related Sites

Government Agency: Ministry of Health and Welfare; Ministry of Food and Drug Safety; Korea Disease Control and Prevention Agency; National Health Insurance Service; Korea Health Industry Development Institute; Health Insurance Review & Assessment Service; Korea Drug Development Fund; National Institute of Health; National Cancer Center; National Institute of Food and Drug Safety Evaluation; Korea Health Information Service

Clinical Trial Center: Cha University Bundang Medical Center; Gachon University Gil Medical Center; The Catholic University Of Korea Seoul St.Mary'S Hospital; Gangnam Severance Hospital; Kyung Hee University Hospital At Gangdong; Konkuk University Medical Center; Kyungpook National University Hospital; Korea University Guro Hospital; Korea University Anam Hospital; Dongguk University Medical Center; Dong-A University Hospital; Bestian Seoul Hospital; Pusan National University Hospital; Seoul National University Bundang Hospital; Samsung Medical Center; Seoul National University Hospital; Asan Medical Center; Severance Hospital; Ajou University Hospital; Yangji Hospital; Wonkwang University Hospital; Ewha Womans University Mokdong Hospital; Inje University Busan Paik Hospital; Inha University Hospital; Chonnam National University Hospital; Jeonbuk National University Hospital; Chungnam National University Hospital; Chungbuk National University Hospital; Ulsan University Hospital; Hallym University Sacred Heart Hospital; Hanyang University Medical Center; Pusan National University Yangsan Hospital

CRO: kolab Health Sciences; PROMEDIS; GSK; D2S; Medical Writing; Synex; SEOUL CRO; SYMYOO; CC&I RESEARCH; C&R RESEARCH; ADM KOREA Inc.; AllLiveC; JNPMEDI; MEDI HELP LINE; BDM Consulting, Inc; LSK Global PS; Caleb Multilab Inc.; IQVIA; CLIPS BnC; PharmaCRO; Linical Korea Co., Ltd.

Analytical CRO/Central LAB: Internationla Scientific Standards; PROMEDIS; GCCL; SML Meditree; Caleb Multilab Inc.

Organization: Korean Research-based Pharma Industry Association; Korea Biomedicine Industry Association; KOREA BIO; Korea Drug Research Association; Korea Pharmaceutical and Bio-Pharma Manufacturers Association
Society/School: Korean Association for the Study of the Liver; The Korean Society of Infectious Diseases; Korean Cancer Association; Korean Academy of Medical Sciences; Korean Cancer Study Group; Innovative Center of Bio-imaging Guided Drug Discovery and Development; The Korean Society of Pharmaceutical Medicine

Information Service: Clinical Research Information Service(Korea Disease Control and Prevention Agency); PHARMA KOREA(Korea Health Industry Development Institute)

Related Agency: (USA) FDA(U.S. Food & Drug Administration); (China) NMPA(National Medical Products Administration); (Europe) EMA(European Medicines Agency); (UK) MHRA(Medicines & Healthcare products Regulatory Agency); (Canada) Health Canada; (Australia) TGA(Therapeutic Goods Administration); (India) CDSCO(Central Drugs Standard Control Organization); (Japan) MHLW(Ministry of Health, Labour, and Welfare); (Japan) PMDA(Pharmaceuticals & Medical Devices Agency); (Singapore) HSA(Health Sciences Authority); (Taiwan) TFDA(Taiwan Food and Drug Administration); (Hong Kong) DO(Drug Office); (Thailand) FDA Thailand; (Vietnam) DAV(Drug Administration of Vietnam); (Indonesia) NA-DFC(Indonesia National Agency of Drug and Food Control); Support Agency; (USA) ACRES(Alliance for Clinical Research Excellence and Safety); (USA) AARHPP(Association for the Accreditation of Human Research Protection Program); (USA) ACRP(Association of Clinical Research Professionals); (USA) CenterWatch; (USA) DIA(Drug Information Association); (USA) NIH(National Institutes of Health); (USA) NCI(National Cancer Institute); (USA) MIT CRITICAL DATA; (USA) TransCelerate; (Europe) ECRIN(European Clinical Research Infrastructure Network); (UK) UKCRC(UK Clinical Research Collaboration); (UK) NIHR(National Institute for Health Research); (Australia) Australian Clinical Trials; (Japan) TRI(Translational Research Informatics Center); (Japan) AMED(Japan Agency for Medical Research and Development); (Singapore) SCRI(Singapore Clinical Research Institute); (Netherlands) IFAPP(International Federation of Associations of Pharmaceutical Physicians); (Saudi Arabia) KAIMRC(King Abdullah International Medical Research Center)

* Criteria for posting CROs: CRO Autonomous Registration Agency

Services Study Feasibility based on EMR data

STUDY FEASIBILITY based on EMR data

For a stakmeholder to enter into Korea for clinical development, it is paramount to identify site feasibility in Korea. Tosupport study feasibility in Korea, KoNECT provides study feasibility service by cooperating with major hospitals, and major hospitals identify the patient population with targetindication based on Electronic Medical Record(EMR) system.

Currently, 40 hospitals and 13 local cancer centers specialized in cancer diseases are participating in the feasibility service as follows. If you wish to participate, please contact us. (E-mail: kontact@konect.or.kr)

Local cancer centers specialized in cancer diseases

Feasibility Inquiry Form

Disclaimer

KoNECT has taken and will continuously take reasonable efforts to provide accurate and up-to-date information, but all information is provided"as is", and we make no warranties as to the accuracy or completeness of information presented, and is not responsible for any errors oromissions. Please refer to our general "Disclaimer of Warranties" described at "Terms of Use".